Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Low-Dose Aspirin Therapy

NCT01568398 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT01568398
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01568398 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Low-Dose Aspirin Therapy
Lead sponsor
Takeda
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2012
Completion date
August 31, 2013
Enrollment
27 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

duodenal ulcer, gastric ulcer